mirCator Platform Development

About Hummingbird Diagnostics

Hummingbird Diagnostics is a privately held, Heidelberg-based biotech founded in 2016, pioneering a novel diagnostic approach. The company's technology platform, mirCator, analyzes small RNAs from whole blood to capture signals from both the disease and the immune system's response, powered by proprietary AI and machine learning software. This integrated analysis aims to create highly sensitive and robust blood tests for early detection and management of cancer and other diseases. The company is in the development stage, building its platform and biomarker database with a seasoned leadership team from diagnostics and computational biology.

Therapeutic Areas